2
R-Biopharm AG announces personnel changes in the Board of Directors and restructuring
more
Stories about Medizin, Gesundheit
A New Ally in Fighting Brain Diseases: Our Very Own Skull
more- 4
PIONEER Big Data in Prostate Cancer Platform Opens up to Asian Data Sets
more Life Science Factory to Open a New Location in Munich in 2024
moreGrünenthal and Kyowa Kirin International Announce Successful Completion of Deal to Enter Joint Venture Collaboration
Aachen, Germany and Tokyo, Japan (ots) - - The Joint Venture Collaboration includes a portfolio of 13 brands across six therapeutic areas, with the majority of revenue resulting from pain management medicines - The new enterprise will be branded as Grünenthal Meds. Grünenthal owns a 51 percent majority share and ...
moreBioNTech and Beyond: New Podcast on German Biopharma
The latest edition of Germany Trade & Invest's German business podcast, Into Germany, features four pharma industry leaders and experts discussing the future of the sector. BioNTech and Beyond is the topic of the latest episode of the monthly German business podcast Into Germany. Helping us understand where German biotech is heading in the wake of the coronavirus pandemis are Laura Matz and Maike Becker-Krüger from the ...
moreTechnische Universität München
4D printing for nerve stimulation: Self-folding electrodes stimulate fine nerves
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Self-folding electrodes stimulate fine nerves 4D printing for nerve stimulation - Researchers have produced very fine, flexible electrodes - Upon contact with tissue moisture, the electrodes wrap themselves around thin nerves - Nerve stimulation and recording with the foldable electrodes has already been demonstrated in ...
more- 4
Sysmex Europe SE launches XR-Series, the new flagship product line for laboratory haematology
One documentmore Press release : STADA further grows its European Consumer Healthcare portfolio by acquiring several additional brands from Sanofi
One documentmorePatientGPT from Semalytix Will Replace Six Months of Evidence & Insight Generation in Life Science with Seconds
moreWildDISCO: Visualizing Whole Bodies in Unprecedented Detail
moreClimate change and heat: What is the impact on people with diabetes?
The increase in heat periods as a result of climate change can be more critical for people with diabetes than for metabolically healthy people. This is especially true at older ages. The article "Heat and diabetes" from diabinfo.de deals with helpful tips for people with diabetes ...
morePotentiating Cancer Vulnerability to Ferroptosis: Off-Targeting Effects of DHODH Inhibitors
more- 2
CARAMBA: New Hope for Multiple Myeloma Patients
more New Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Induction
morePM: Bessere Logistik für eine bessere Gesundheitsversorgung: DHL-Whitepaper identifiziert Trends, Änderungen und Lösungen im Supply-Chain-Management des Life-Sciences- und Healthcare-Sektors / PR: Advancing healthcare delivery: DHL white paper identi
moreTechnische Universität München
Robotics and AI at the automatica: practical insights into leading-edge research
TECHNICAL UNIVERSITY OF MUNICH PRESS RELEASE Bavarian Science Minister Markus Blume opens munich_i Robotics and AI: practical insights into leading-edge research - More than 30 new demonstrations on view at the AI.Society exhibition - Leading experts in robotics and AI to meet at the Hightech Summit. - Third Robothon prize for talented young robotics researchers to be ...
moreRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
moreEmpowering the Future of Pain Relief Research: Recipients of the 2023 EFIC-Grünenthal Grant Announced
Brussels/Aachen (ots) - - Three promising early-career scientists have been awarded the prestigious EFIC-Grünenthal Grant (E-G-G) 2023. - The E-G-G funds innovative research projects to advance understanding of pain and improve the lives of people suffering from pain. The European Pain Federation EFIC® and the ...
moreArtilysin® - A Groundbreaking "Green Pharma" Solution
more- 2
Press Release: Aurubis subsidiary RETORTE expanding selenium production for profitable growth markets
One documentmore - 2
Study Reveals Influence of Urban Environment on Mental Health
more Press release: STADA appoints Christos Gallis as Head of Eastern Europe
One documentmoreBerlin Cures Welcomes Oliver von Stein as New CEO to Lead Next Phase of Innovation and Growth / Phase II study for BC 007 in the indication Long COVID to start in June
moreCroma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China
Vienna (ots/PRNewswire) - Croma-Pharma® ('Croma') announced today that in June the first patient will be enrolled in the clinical trial1 for the approval of its hyaluronic acid dermal filler Princess® Volume Plus Lidocaine2 in China. The randomised, multi-centre, evaluator blinded, parallel group, active ...
moreFirst Integrated Single-Cell Atlas of the Human Lung
Can a human organ be mapped on a single-cell level to learn about the functionality of each individual cell? And can we learn how different these cells are from person to person? Helmholtz Munich researchers and their collaborators have taken up this challenge and developed the Human Lung Cell Atlas using artificial intelligence (AI)-based techniques. This atlas elucidates the diversity of single lung cell types and ...
moreLTS Lohmann Therapie-Systeme AG
LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business
moreJoint Statement: health organisations define EHDS’ opt-out required for life-saving research
One documentmoreUnraveling the Mode of Action of Tirzepatide
Tirzepatide is a recently approved treatment for type-2 diabetes. Treatment with tirzepatide decreases body weight while improving glucose metabolism in patients with obesity and type-2 diabetes. Although the drug is designed to activate receptors for glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), the contribution of activating the GIP receptor in the overall efficacy of ...
more- 2
PM: „Get Airports Ready for Disaster“-Programm in Sarajevo / PR: Get Airports Ready for Disaster Program held in Sarajevo
2 Documentsmore
Previous234567891011Next